Hello. Sign in to personalize your visit. New user? Register now.  
Journal of Ocular Pharmacology and Therapeutics
Tolerability and Efficacy of N-Chlorotaurine in Epidemic Keratoconjunctivitis—a Double-Blind, Randomized, Phase-2 Clinical Trial

To cite this article:
Barbara Teuchner, Markus Nagl, Axel Schidlbauer, Hiroaki Ishiko, Ernst Dragosits, Hanno Ulmer, Koki Aoki, Shigeaki Ohno, Nobuhisa Mizuki, Waldemar Gottardi, Clara Larcher. Journal of Ocular Pharmacology and Therapeutics. April 2005, 21(2): 157-165. doi:10.1089/jop.2005.21.157.

Full Text: • PDF for printing (75.1 KB) • PDF w/ links (120.4 KB)


Barbara Teuchner
Department of Ophthalmology, Innsbruck Medical University, Innsbruck, Austria.
Markus Nagl
Department of Hygiene, Microbiology and Social Medicine, Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria.
Axel Schidlbauer
Department of Ophthalmology, Innsbruck Medical University, Innsbruck, Austria.
Hiroaki Ishiko
Mitsubishi Kagaku Bio-Clinical Laboratories, Inc., Tokyo, Japan.
Ernst Dragosits
Department of Ophthalmology, Innsbruck Medical University, Innsbruck, Austria.
Hanno Ulmer
Department of Medical Statistics, Informatics, and Health Economics, Innsbruck Medical University, Innsbruck, Austria.
Koki Aoki
Department of Ophthalmology, Yokohama City University School of Medicine, Yokohama, Japan.
Shigeaki Ohno
Department of Ophthalmology and Visual Sciences, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Nobuhisa Mizuki
Department of Ophthalmology, Yokohama City University School of Medicine, Yokohama, Japan.
Waldemar Gottardi
Department of Hygiene, Microbiology and Social Medicine, Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria.
Clara Larcher
Department of Hygiene, Microbiology and Social Medicine, Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria.

The aim of this study was to assess the tolerability and efficacy of N-chlorotaurine (NCT), an endogenous antimicrobial agent, in epidemic keratoconjunctivitis. In a prospective double- blind, randomized phase 2b study, the infected eyes were treated for 7 days with eye drops containing 1% aqueous solution of N-chlorotaurine (33 subjects) or gentamicin (27 subjects, control group). Adenovirus types 3, 4, 8, 19, and 37 were detected in 39 subjects (65%), enteroviruses in 8 (13.3%), and staphylococci in 5 (8.3%). Subjective and objective symptoms were scaled and added to a subjective and objective score, respectively, on day 1 (baseline), day 4, and day 8. Analyzing the whole study population, the subjective score on day 8 was lower in the NCT group (P = 0.016), whereas there were no differences in the objective score. However, in severe infections caused by adenovirus type 8 (n = 20) both the subjective and objective score were lower in the NCT group on day 4 (P = 0.003 and 0.015, respectively), which was also true for the subjective score on day 8 (P = 0.004) in this subgroup. The frequency of subepithelial infiltrates was similar in both groups. N-chlorotaurine was well-tolerated, shortened the duration of illness, and seems to be a useful causative therapeutic approach in severe epidemic keratoconjunctivitis.

Free first page

This paper was cited by:

Tolerability of N-chlorotaurine plus ammonium chloride in the rabbit and human eye - a phase 1 clinical study
Barbara Teuchner, Eduard Schmid, Hanno Ulmer, Waldemar Gottardi, Markus Nagl
Graefe's Archive for Clinical and Experimental Ophthalmology. Jan 2009, Vol. 246, No. 12: 1723-1730
CrossRef
Clinical features and treatment of adenovirus infections
Liesbeth Lenaerts, Erik De Clercq, Lieve Naesens
Reviews in Medical Virology. Dec 2008, Vol. 18, No. 6: 357-374
CrossRef
Effect of N-chlorotaurine mouth rinses on plaque regrowth and plaque vitality
K. Lorenz, D. Mayer, G. Bruhn, B. Noack, M. Brecx, C. Heumann, H. Toutenburg, L. Netuschil, M. Nagl, W. Gottardi, T. Hoffmann
Clinical Oral Investigations. Jul 2008
CrossRef
Protein sites of attack ofN-chlorotaurine inEscherichia coli
Roland Arnitz, Bettina Sarg, Helmut W. Ott, Andreas Neher, Herbert Lindner, Markus Nagl
PROTEOMICS. Mar 2006, Vol. 6, No. 3: 865-869
CrossRef
N,N-Dichlorotaurine: Chemical and Bactericidal Properties
Waldemar Gottardi, Magdalena Hagleitner, Markus Nagl
Archiv der Pharmazie. Nov 2005, Vol. 338, No. 10: 473-483
CrossRef
All articles
Previous Next